1GA
JAZZ icon

1st Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

1st Global Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,120
Closed -$258K – 527
2016
Q3 		$258K Buy
2,120
+156
+8% +$21K 0.03% 413
2016
Q2 		$278K Buy
1,964
+93
+5% +$13.7K 0.04% 370
2016
Q1 		$244K Buy
+1,871
New +$233K 0.03% 408
2015
Q4 		– Sell
-1,764
Closed -$234K – 464
2015
Q3 		$234K Buy
1,764
+65
+4% +$11.2K 0.04% 372
2015
Q2 		$299 Buy
1,699
+133
+8% +$23.9K 0.04% 331
2015
Q1 		$271K Buy
1,566
+91
+6% +$15.6K 0.04% 361
2014
Q4 		$242K Buy
1,475
+173
+13% +$28.7K 0.03% 384
2014
Q3 		$209K Buy
+1,302
New +$200K 0.03% 407

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1st Global Advisors's JAZZ Position: Q4 2016 in Review

1st Global Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2016, closing a stake of 2,120 shares — an estimated $258K sold.

1st Global Advisors first reported a position in JAZZ in Q3 2014 and held it in 8 quarters. The position peaked at $278K in Q2 2016. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

  • 1st Global Advisors reported no remaining Jazz Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • 1st Global Advisors sold 2,120 Jazz Pharmaceuticals shares in Q4 2016, an estimated $258K.
  • 1st Global Advisors first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 8 quarters.
  • 1st Global Advisors's Jazz Pharmaceuticals position peaked at $278K in Q2 2016.
  • 295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on 1st Global Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.